ArticleHepatology communications2022

Reply to: "Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD".

Laurens A van Kleef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.